20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing
Go back to 20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing| (NASDAQ: AIDX) | Delayed: 0.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $ | |||
| Open | $0.61 | 52 Week Low | $ | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.61 | EPS | $ | |||
| Volume | 3,886 | |||||

